Levomed (Levodopa, Anhydrous Carbidopa)

Levodopa serves as a precursor that crosses the blood‑brain barrier and is converted into dopamine within central nervous system neurons. The added carbidopa blocks peripheral conversion of levodopa, allowing more of the drug to reach the brain and minimizing peripheral side effects such as nausea.

The appropriate dose of Levomed is individualized by the prescribing clinician based on the patient's disease severity, response to therapy, age, renal and hepatic function, and any concomitant medications. No standard dosing regimen is provided here; the prescriber sets the regimen.

Safety data for levodopa/carbidopa in pregnancy and lactation are limited. The product is generally categorized as contraindicated or to be used only if the potential benefit justifies the potential risk. Patients who are pregnant, planning pregnancy, or breastfeeding should discuss risks with their healthcare provider.

To request Levomed, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details and any required import documentation.

Levomed contains the same active components as other levodopa/carbidopa products such as Sinemet, but may differ in tablet strength, excipients, or regulatory status. Compared with dopamine agonists, levodopa/carbidopa provides more potent symptomatic relief but carries a higher risk of motor complications over long‑term use.

Levomed should be stored at ambient temperature, preferably below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and extreme heat to maintain stability and potency throughout its shelf life.

Levomed is taken orally, usually with a glass of water. Tablets should be swallowed whole and can be taken with or without food, although a light meal may reduce gastrointestinal upset. Dosing times are typically spaced evenly throughout the day as directed by the prescriber.

Serious adverse events include neuroleptic malignant syndrome, severe depression or suicidal ideation, and psychotic reactions such as hallucinations. These conditions require immediate medical attention and may necessitate discontinuation of therapy.

Levomed is contraindicated in patients with known hypersensitivity to levodopa, carbidopa, or any excipients. It should also be avoided in individuals currently receiving non‑selective MAO inhibitors, and used with caution in patients with severe cardiovascular disease, uncontrolled hypertension, or a history of psychiatric disorders.